文献速递头颈部肿瘤放疗放疗物理与技术

人工智能赋能的多步骤一体化放疗工作流用于鼻咽癌

Artificial Intelligence-Empowered Multistep Integrated Radiation Therapy Workflow for Nasopharyngeal Carcinoma.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2024-12-19

前瞻性纳入120例新诊断非转移性鼻咽癌患者,评估人工智能赋能的多步骤一体化放疗工作流的可行性与临床表现。117例完成工作流,中位时长23.2分钟,AI生成计划首次优化通过率92.3%,115例放疗后12周达完全缓解。

要点

  • 117例完成AI赋能多步骤一体化放疗工作流,中位时长23.2分钟(范围16.3-45.8)。
  • AI生成计划108例(92.3%)首次优化通过,≥97.8%靶区接受≥100%处方剂量。
  • 115例放疗后12周达完全缓解,14例报告任何急性毒性为「非常严重」。

核心结论

  • 在单机构环境下,人工智能赋能的多步骤一体化放疗工作流用于鼻咽癌患者临床可行,并与标准人工放疗工作流进行了比较。

研究设计与样本

  • 前瞻性纳入120例新诊断、非转移性鼻咽癌患者,计划接受多步骤一体化放疗工作流。
  • 该工作流整合从CT扫描到束流出束的放疗流程,全部在治疗床上完成。
  • 评估工作流性能、肿瘤缓解、患者报告的急性毒性和生活质量。

主要发现

  • 2022年3月至2023年10月纳入120例患者,其中117例完成工作流,中位时长23.2分钟(范围16.3-45.8)。
  • 中位平移误差为0.2 mm(从CT扫描到计划批准)和0.1 mm(束流出束期间)。
  • AI生成轮廓在高危临床靶区和危及器官需最小修订,在受累颈部淋巴结和低危临床靶区需轻微修订(中位DSC分别为0.98和0.94),在原发灶肿瘤和受累咽后淋巴结需更多修订(中位DSC为0.84)。
  • 117例AI生成计划中108例(92.3%)首次优化后通过,≥97.8%的靶区接受≥100%处方剂量;大多数危及器官满足剂量学约束,但甲状腺和下颌下腺除外。
  • 115例患者在放疗后12周达完全缓解,14例报告从放疗开始至放疗后12周任何急性毒性为「非常严重」。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To establish an artificial intelligence (AI)-empowered multistep integrated (MSI) radiation therapy (RT) workflow for patients with nasopharyngeal carcinoma (NPC) and evaluate its feasibility and clinical performance. METHODS AND MATERIALS: Patients with NPC scheduled for MSI RT workflow were prospectively enrolled. This workflow integrates RT procedures from computed tomography (CT) scan to beam delivery, all performed with the patient on the treatment couch. Workflow performance, tumor response, patient-reported acute toxicities, and quality of life were evaluated. RESULTS: From March 2022 to October 2023, 120 newly diagnosed, nonmetastatic patients with NPC were enrolled. Of these, 117 completed the workflow with a median duration of 23.2 minutes (range, 16.3-45.8). Median translation errors were 0.2 mm (from CT scan to planning approval) and 0.1 mm (during beam delivery). AI-generated contours required minimal revision for the high-risk clinical target volume and organs at risk, minor revision for the involved cervical lymph nodes and low-risk clinical target volume (median Dice similarity coefficients (DSC), 0.98 and 0.94), and more revision for the gross tumor at the primary site and the involved retropharyngeal lymph nodes (median DSC, 0.84). Of 117 AI-generated plans, 108 (92.3%) passed after the first optimization, with ≥97.8% of target volumes receiving ≥100% of the prescribed dose. Dosimetric constraints were met for most organs at risk, except the thyroid and submandibular glands. One hundred and fifteen patients achieved a complete response at week 12 post-RT, while 14 patients reported any acute toxicity as "very severe" from the start of RT to week 12 post-RT. CONCLUSIONS: AI-empowered MSI RT workflow for patients with NPC is clinically feasible in a single institutional setting compared with standard, human-based RT workflow.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Yang YX, Yang X, Jiang XB, et al. Artificial Intelligence-Empowered Multistep Integrated Radiation Therapy Workflow for Nasopharyngeal Carcinoma. Int J Radiat Oncol Biol Phys. 2024. PMID: 39708045. doi:10.1016/j.ijrobp.2024.11.096

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。